Gilead Sciences Inc has begun marketing its HIV treatment Truvada in a way thousands of consumers already use it – to prevent infection with the virus that causes AIDS. The company introduced Truvada ...
What are the most promising treatments in development for HIV? originally appeared on Quora: the knowledge sharing network where compelling questions are answered by people with unique insights.
Please provide your email address to receive an email when new articles are posted on . The International Antiviral Society-USA will host a 2-day virtual course this month titled, “From CROI to the ...
This past Winter Session, 12 University students traveled to Israel as part of BIOL 1980: “HIV/AIDS in Diverse Settings: Focus on Israel.” The course examines HIV/AIDS in the context of Israel’s ...
In an advance for HIV vaccine research, a scientific team has discovered how the immune system makes a powerful antibody that blocks HIV infection of cells by targeting a site on the virus called V1V2 ...
Early treatment often best course in HIV An international panel has updated its guidelines on when to start treatment. With the risks of HIV antiretroviral therapy (ART) decreasing and concerns ...
A class about HIV and AIDS at ASU provides the sexual education many students do not receive in public schools. All the while, college-aged adults in Arizona have some of the highest rates of HIV ...
Kaitlyn Simons, freshman in LAS, and each member of her group project have been going to McKinley Health Center and collecting a package of condoms every two weeks. This is part of a project to ...
Thanks to sustained political leadership, unprecedented funding from bilateral and multilateral sources, and the adoption of innovative service delivery approaches in the face of a humanitarian crisis ...
A three-dose course of the hepatitis B vaccine HEPLISAV-B fully protected adults living with HIV who had never been vaccinated against or infected with the hepatitis B virus (HBV), according to study ...
With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...
NEW YORK (Reuters) - Gilead Sciences Inc has begun marketing its HIV treatment Truvada in a way thousands of consumers already use it – to prevent infection with the virus that causes AIDS. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback